North America Reproductive Health Diagnostics Market Outlook to 2033: Prenatal Screening and Reproductive Hormones and Proteins Tests

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: July 09, 2025 Report Code: GDME20434CRDB-ST

Select Item

GlobalData’s “North America Reproductive Health Diagnostics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Reproductive Health Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Prenatal Screening and Reproductive Hormones and Proteins Tests

The North America Reproductive Health Diagnostics Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Reproductive Health Diagnostics Market.
• Global corporate-level profiles of key companies operating within the North America Reproductive Health Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Reproductive Health Diagnostics is segmented as follows –

• Prenatal Screening

• Reproductive Hormones and Proteins Tests

Reasons to Buy

The North America Reproductive Health Diagnostics Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Reproductive Health Diagnostics Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Reproductive Health Diagnostics Market, North America 11

3.1 Reproductive Health Diagnostics Market, North America, Revenue ($m), 2018-2033 11

3.2 Reproductive Health Diagnostics Market, North America, Revenue ($m), 2018-2033 13

3.3 Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033 15

3.4 Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033 16

3.5 Reproductive Health Diagnostics Market, North America, Company Share by Revenue ($m), 2024 18

4 Reproductive Health Diagnostics Market, Mexico 20

4.1 Reproductive Health Diagnostics Market, Mexico, Revenue ($m), 2018-2033 20

4.1.1 Prenatal Screening Market, Mexico, Revenue ($m), by Segment, 2018-2033 22

4.1.2 Reproductive Hormones and Proteins Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 24

4.2 Reproductive Health Diagnostics Market, Mexico, Volume (Units), 2018-2033 26

4.2.1 Prenatal Screening Market, Mexico, Volume (Units), by Segment, 2018-2033 28

4.2.2 Reproductive Hormones and Proteins Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 31

4.3 Reproductive Health Diagnostics Market, Mexico, Average Price ($), 2018-2033 34

4.4 Reproductive Health Diagnostics Market, Mexico, Company Share by Revenue ($m), 2024 36

5 Reproductive Health Diagnostics Market, Canada 38

5.1 Reproductive Health Diagnostics Market, Canada, Revenue ($m), 2018-2033 38

5.1.1 Prenatal Screening Market, Canada, Revenue ($m), by Segment, 2018-2033 40

5.1.2 Reproductive Hormones and Proteins Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 42

5.2 Reproductive Health Diagnostics Market, Canada, Volume (Units), 2018-2033 44

5.2.1 Prenatal Screening Market, Canada, Volume (Units), by Segment, 2018-2033 46

5.2.2 Reproductive Hormones and Proteins Tests Market, Canada, Volume (Units), by Segment, 2018-2033 49

5.3 Reproductive Health Diagnostics Market, Canada, Average Price ($), 2018-2033 52

5.4 Reproductive Health Diagnostics Market, Canada, Company Share by Revenue ($m), 2024 54

6 Reproductive Health Diagnostics Market, United States 56

6.1 Reproductive Health Diagnostics Market, United States, Revenue ($m), 2018-2033 56

6.1.1 Prenatal Screening Market, United States, Revenue ($m), by Segment, 2018-2033 58

6.1.2 Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), by Segment, 2018-2033 60

6.2 Reproductive Health Diagnostics Market, United States, Volume (Units), 2018-2033 62

6.2.1 Prenatal Screening Market, United States, Volume (Units), by Segment, 2018-2033 64

6.2.2 Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), by Segment, 2018-2033 67

6.3 Reproductive Health Diagnostics Market, United States, Average Price ($), 2018-2033 70

6.4 Reproductive Health Diagnostics Market, United States, Company Share by Revenue ($m), 2024 72

7 Overview of Key Companies in North America Reproductive Health Diagnostics Market 74

7.1 Illumina Inc 74

7.1.1 Company Overview 74

7.2 Quidelortho Corp 74

7.2.1 Company Overview 74

7.3 Danaher Corp 74

7.3.1 Company Overview 74

7.4 F. Hoffmann-La Roche Ltd 74

7.4.1 Company Overview 74

7.5 Siemens AG 75

7.5.1 Company Overview 75

7.6 Abbott Laboratories 75

7.6.1 Company Overview 75

7.7 BGI Genomics Co Ltd 75

7.7.1 Company Overview 75

8 Reproductive Health Diagnostics Market Pipeline Products 76

9 Recent Developments 86

9.1 Strategy And Business Planning 86

9.1.1 Apr 22, 2025: Advantia Health Teams Up With Mirvie to Bring Predictive and Preventive Care to Maternal Health 86

10 Appendix 87

10.1 Research Methodology 88

10.1.1 Coverage 88

10.1.2 Secondary Research 88

10.1.3 Primary Research 88

10.1.4 Market Modeling and Forecasting 89

10.1.5 Company Share Analysis 90

10.1.6 Benchmarking 91

10.2 GlobalData Consulting 92

10.3 Contact Us 92

10.4 Disclaimer 92

Table

Table 1: Reproductive Health Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 12

Table 2: Reproductive Health Diagnostics Market, North America, Revenue ($m), USD Constant, 2018-2033 14

Table 3: Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033 15

Table 4: Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033 17

Table 5: Reproductive Health Diagnostics Market, North America, Company Share by Revenue ($m), 2024 19

Table 6: Reproductive Health Diagnostics Market, Mexico, Revenue ($m), USD Constant, 2018-2033 21

Table 7: Prenatal Screening Market, Mexico, Revenue ($m), USD Constant, 2018-2033 23

Table 8: Reproductive Hormones and Proteins Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033 25

Table 9: Reproductive Health Diagnostics Market, Mexico, Volume (Units), 2018-2033 27

Table 10: Prenatal Screening Market, Mexico, Volume (Units), 2018-2033 29

Table 11: Reproductive Hormones and Proteins Tests Market, Mexico, Volume (Units), 2018-2033 32

Table 12: Reproductive Health Diagnostics Market, Mexico, Average Price ($), 2018-2033 34

Table 13: Reproductive Health Diagnostics Market, Mexico, Company Share by Revenue ($m), 2024 37

Table 14: Reproductive Health Diagnostics Market, Canada, Revenue ($m), USD Constant, 2018-2033 39

Table 15: Prenatal Screening Market, Canada, Revenue ($m), USD Constant, 2018-2033 41

Table 16: Reproductive Hormones and Proteins Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033 43

Table 17: Reproductive Health Diagnostics Market, Canada, Volume (Units), 2018-2033 45

Table 18: Prenatal Screening Market, Canada, Volume (Units), 2018-2033 47

Table 19: Reproductive Hormones and Proteins Tests Market, Canada, Volume (Units), 2018-2033 50

Table 20: Reproductive Health Diagnostics Market, Canada, Average Price ($), 2018-2033 52

Table 21: Reproductive Health Diagnostics Market, Canada, Company Share by Revenue ($m), 2024 55

Table 22: Reproductive Health Diagnostics Market, United States, Revenue ($m), USD Constant, 2018-2033 57

Table 23: Prenatal Screening Market, United States, Revenue ($m), USD Constant, 2018-2033 59

Table 24: Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 61

Table 25: Reproductive Health Diagnostics Market, United States, Volume (Units), 2018-2033 63

Table 26: Prenatal Screening Market, United States, Volume (Units), 2018-2033 65

Table 27: Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), 2018-2033 68

Table 28: Reproductive Health Diagnostics Market, United States, Average Price ($), 2018-2033 70

Table 29: Reproductive Health Diagnostics Market, United States, Company Share by Revenue ($m), 2024 73

Table 30: Reproductive Health Diagnostics Market Pipeline Products 76

Table 31: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 89

Figures

Figure 1: Reproductive Health Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 11

Figure 2: Reproductive Health Diagnostics Market, North America, Revenue ($m), USD Constant, 2018-2033 13

Figure 3: Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033 15

Figure 4: Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033 16

Figure 5: Reproductive Health Diagnostics Market, North America, Company Share (%), 2024 18

Figure 6: Reproductive Health Diagnostics Market, Mexico, Revenue ($m), USD Constant, 2018-2033 20

Figure 7: Prenatal Screening Market, Mexico, Revenue ($m), USD Constant, 2018-2033 22

Figure 8: Reproductive Hormones and Proteins Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033 24

Figure 9: Reproductive Health Diagnostics Market, Mexico, Volume (Units), 2018-2033 26

Figure 10: Prenatal Screening Market, Mexico, Volume (Units), 2018-2033 28

Figure 11: Reproductive Hormones and Proteins Tests Market, Mexico, Volume (Units), 2018-2033 31

Figure 12: Reproductive Health Diagnostics Market, Mexico, Company Share (%), 2024 36

Figure 13: Reproductive Health Diagnostics Market, Canada, Revenue ($m), USD Constant, 2018-2033 38

Figure 14: Prenatal Screening Market, Canada, Revenue ($m), USD Constant, 2018-2033 40

Figure 15: Reproductive Hormones and Proteins Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033 42

Figure 16: Reproductive Health Diagnostics Market, Canada, Volume (Units), 2018-2033 44

Figure 17: Prenatal Screening Market, Canada, Volume (Units), 2018-2033 46

Figure 18: Reproductive Hormones and Proteins Tests Market, Canada, Volume (Units), 2018-2033 49

Figure 19: Reproductive Health Diagnostics Market, Canada, Company Share (%), 2024 54

Figure 20: Reproductive Health Diagnostics Market, United States, Revenue ($m), USD Constant, 2018-2033 56

Figure 21: Prenatal Screening Market, United States, Revenue ($m), USD Constant, 2018-2033 58

Figure 22: Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 60

Figure 23: Reproductive Health Diagnostics Market, United States, Volume (Units), 2018-2033 62

Figure 24: Prenatal Screening Market, United States, Volume (Units), 2018-2033 64

Figure 25: Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), 2018-2033 67

Figure 26: Reproductive Health Diagnostics Market, United States, Company Share (%), 2024 72

North America Reproductive Health Diagnostics Market Outlook to 2033: Prenatal Screening and Reproductive Hormones and Proteins Tests standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Reproductive Health Diagnostics Market Outlook to 2033: Prenatal Screening and Reproductive Hormones and Proteins Tests in real time.

  • Access a live North America Reproductive Health Diagnostics Market Outlook to 2033: Prenatal Screening and Reproductive Hormones and Proteins Tests dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more